manufacturing Archives

Industry 4.0 for MSMEs

August 4, 2023August 4, 2023by valueaddedinLeave a comment

Conference on “Industry 4.0 for MSMEs” on 23rd August 2023, Wednesday

The adoption of Industry 4.0 technologies, such as automation and IoT, is essential for the manufacturing of MSMEs in the future. These technologies provide substantial advantages, such as increased visibility, productivity, competitiveness, and efficiency, all of which are essential for MSME manufacturers to maintain their lead in the global market. MSME manufacturers can successfully adopt Industry 4.0 principles and modernize their processes to satisfy future demands.

Considering the importance of this, Andhra Chamber of Commerce in association with Friedrich Naumann Foundation for Freedom is organizing a Conference on “Industry 4.0 for MSMEs” on the 23rd August 2023 in Hotel Hyatt Regency, Anna Salai, Chennai from 10 a.m. to 4 p.m.

The learnings of the Conference will

make the MSMEs more competitive
make the MSMEs more attractive to the younger workforce
make the team stronger and more collaborative.
allow the MSMEs to address potential issues before they become big problems.
allow the MSMEs to trim costs, boost profits, and fuel growth

Target audience: MSMEs, Consultants, Academicians, CEOs of Industries etc.,
Participation fee:

Program Details:

Venue: Hotel Hyatt Regency, Anna Salai, Chennai 2

Date: 23rd August 2023 (Wednesday)

Time: 10 a.m. to 4 p.m

There is no participation fee but registration is must.

Click here to fill up online registration form .

Click here to download registration form

As the participation is only on the first come first served basis, please fill up the registration form and send it to Andhra Chamber of Commerce at the earliest.

Industry information update – Medical devices

July 5, 2023July 5, 2023by valueaddedinLeave a comment

DoP releases strategy document to fine tune & implement National Medical Devices Policy

In an effort to fine tune and proceed with the implementation of the National Medical Devices Policy, 2023, launched in the month of May, the Department of Pharmaceuticals (DoP) has come out with an elaborate strategy document which emphasises on data security measures, adoption of national nomenclature for medical devices, a strategy to manage e-waste of obsolete medical devices and strengthening of technology transfer capabilities in the sector.

It would also work towards providing awareness to the innovatory community on regulator compliance, early on in the product development cycle through structured programmes using course curriculum, skill training or workshops, it said.

The NMDP, 2023 covers six broad areas of work for the promotion of the medical devices industry including regulatory streamlining, enabling infrastructures, facilitating research and development and innovation, attracting investments in the sector, human resource development and brand positioning and awareness creation.

As part of infrastructure development, the strategy document states, “”In close coordination with the ministry of environment, forest and climate changes, processes will be developed for e-waste management of obsolete medical devices”.

“The Policy strives to create an ecosystem to promote Research and Innovation in the sector under the ambit of the department’s proposed separate ‘Policy to Catalyse R&D and Innovation in the Pharma-MedTech Sector in India’”

Besides, a mechanism will be put in place to hand-hold the innovators and IP holders towards commercialisation of the products

Under the fiscal and non-fiscal measures to attract investments in the sector, it looks at incubation support for start ups in the R&D and innovation, mentorship for entrepreneurs along with skill development, such as business management, market access and commercialisation efforts for the innovation solutions developed, technology transfer mechanism for innovative solutions and relations for start-ups in compliance and regulatory regime.

Under the human resources development strategy, it envisages that since the human resources in the field of design are limited, the National Institutes of Design (NID) and private design schools will be encouraged to teach design centric courses to fill the gap, it added.

Click here to read the Strategy document

Source:https://pharmaceuticals.gov.in/policy/strategy-document-national-medical-devices-policy-2023

Source:http://www.pharmabiz.com/NewsDetails.aspx?aid=160035&sid=1

BSI Launch Event: Antimicrobial Resistance (AMR) certification

June 22, 2023June 22, 2023by valueaddedinLeave a comment

BSI Antimicrobial Resistance (AMR) Certification – Launch event on Monday, 26th June 2023 between 15:00 hrs – 16:30hrs (IST)

According to the World Health Organization, antimicrobial resistance (AMR) has been declared a top 10 global public health threat and is expected to get worse unless action is taken. It threatens to undermine the basis of modern medicine by rendering the antibiotics used to treat and prevent infections ineffective.

Resistance can come from many sources – BSI is working with the pharmaceutical industry to focus on the evolution of responsible manufacturing of antibiotics. Manufacturing waste from the production of antibiotics may contribute to the development of AMR in the environment unless emissions from waste streams are effectively controlled

BSI, in collaboration with the AMR Industry Alliance, will launch an industry antibiotic manufacturing certification scheme on 26 June 2023

This independent and impartial certification program is perfectly situated to serve as a mechanism for antibiotic manufacturers to demonstrate evolving best practice and compliance to the Antibiotic Manufacturing Standard. While government regulators have a role to play in promoting responsible manufacturing, the industry has shown its willingness to self-regulate by developing this manufacturing standard and independent certification scheme.

Companies including Centrient, Roche, Pfizer, Teva, Viatris, and Sandoz were participants in the pilot program and have helped provide technical expertise to shape the certification program.

Provide independent third-party assurance that your organization is minimizing the risk of waste emissions from manufacturing
Prove that the industry can self-regulate the antimicrobial resistance topic through certification and external third-party independent assessments
Differentiate yourselves in healthcare systems tenders by showing your antibiotic products are independently certified by a trusted organization with a recognizable Mark of Trust

Who should attend?